Venus Remedies incorporated in 1989, is a pharmaceutical manufacturing company. The company provides formulations in area of anti-biotics and oncological therapeutics.

Company has two manufacturing facilities located in India and Germany. Company manufactures Oncological and Cefelosporine Injectable products.

Its manufacturing facility located in India has received ISO 9001, ISO, 14001 and OHSAS 18001 for quality management. Its Germany facility follows EU-GMP norms.

Presently, the company has successfully made its presence in the markets of Philippines, Thailand, Malaysia, Cambodia, Burma, Vietnam, Sri Lanka, Pakistan, Bangladesh, Nepal, Uganda, Kenya, Botswana, Zimbabwe, Sudan, Mauritius, Yemen, Iraq, Russia, Belarus, Ukraine, Costa Rica, Venezuela, Guatemala, Peru, Colombia, Ecuador, Syria, Yeman, Togo, Saudi Arbia and Iraq.

Company has entered into strategic alliances with various pharmaceutical companies to launch its R&D based specialty products. It has tie-ups with companies namely IPCA Laboratories, Elder Pharmaceuticals, Shreya Lifesciences, Cadila Healthcare, Glenmark Pharmaceuticals, Marksans Pharma, Indoco Remedies, Karle Health Sciences, Lupin and Jagsonpal Pharmaceuticals.

Company also conducts in-house research and development activities that focuses Formulation Development, NDDS (Novel Drug Delivery System), new formulations of off patented chemicals and analytical and chemical research.

Products

The company is engaged in manufacturing products catering various segments such as Oncology, Cephalosporins, Carbapenems and Other Specialties, Intravenous Products, Vials/Lyophilized Injectables, Pre-Filled Syringes, Hormones, Ampoules and Biological Products.

Venus Remedies Ltd.

Kilitch Drugs (India) Ltd.

Krebs Biochemicals & Industries Ltd.

Brooks Laboratories Ltd.

Bafna Pharmaceuticals Ltd.

Mangalam Drugs And Organics Ltd.

SMS Lifesciences India Ltd.

Wanbury Ltd.

Albert David Ltd.

Lyka Labs Ltd.

Bal Pharma Ltd.

Lasa Supergenerics Ltd.

Vaishali Pharma Ltd.

Ind-Swift Laboratories Ltd.

Alpa Laboratories Ltd.

HDFC Bank Ltd.

ICICI Bank Ltd.

ITC Ltd.

Reliance Industries Ltd.

Tata Motors Ltd.

Market Cap	252 Cr		EPS	21.8		High	202
Stock P/E	8.7		Net Profit Margin	3.8		Low	197.55

Market Cap	252 Cr	ROE	9.8%
P/E Ratio(TTM)	8.7	EPS(TTM)	26.9
P/B Ratio	0.5	Dividend Yield	0.0%
Industry P/E	63.6	Book Value	350.4
		Face Value	10.0

VENUSREM